3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Participation
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Interventions
venetoclax
21
Cyclophosphamide
14
Cytarabine
12
Azacitidine
8
fludarabine
7
Dexamethasone
5
Daunorubicin
5
ruxolitinib
4
revumenib
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
quizartinib
3
pirtobrutinib
3
gamma-Globulins
3
fludarabine phosphate
3
blinatumomab
3
Tacrolimus
3
Rituximab
3
Palliative Care
3
Inotuzumab Ozogamicin
3
Granulocyte Colony-Stimulating Factor
3
Decitabine
3
Ciprofloxacin
3
Blood Specimen Collection
3
zanubrutinib
2
ponatinib
2
pembrolizumab
2
ibrutinib
2
aldesleukin
2
acalabrutinib
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia
×
Blood Transfusion
×
Clear all
NCT07258043
2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
45 enrolled